ArticleMacromolecular bioscience2026
Enhancing the Antimicrobial Potency of Self-Assembling Antibiotics by Co-Assembly-Based Aggregation Modulation.
Article in Macromolecular bioscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The activity of many antimicrobial peptides (AMPs), a promising alternative to classical antibiotics, depends strongly on their aggregation-propensity and weak peptide association favor antimicrobial function, whereas stable assembly can reduce activity. Thus, modulation of intermolecular interactions offers a feasible way to enhance the potency of existing AMPs. However, a general strategy to achieve this objective has not been established. Here, we demonstrate that the spectrum of activity of Gram-positive-specific self-assembling AMP Fmoc-phenylalanine can be broadened by co-assembly with non-antibiotic Fmoc-glutamic acid. Biophysical assays confirmed that the co-assembled system disrupted bacterial membrane integrity, leading to cell death. The enhanced potency correlated with the reduced mechanical rigidity of the co-assembled hydrogel, as determined by rheological measurements, and molecular dynamics simulations further revealed that heterogeneous non-covalent interactions were detrimental to the fibril stability. These findings suggest that rationally designed co-assembling partners that weaken stabilizing non-covalent interactions can serve as a common strategy to enhance the antibacterial efficacy of existing AMPs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.